These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 2105269)

  • 1. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
    Ivins BE; Welkos SL; Knudson GB; Little SF
    Infect Immun; 1990 Feb; 58(2):303-8. PubMed ID: 2105269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.
    Welkos SL; Friedlander AM
    Microb Pathog; 1988 Aug; 5(2):127-39. PubMed ID: 3148815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.
    Ivins BE; Welkos SL; Little SF; Crumrine MH; Nelson GO
    Infect Immun; 1992 Feb; 60(2):662-8. PubMed ID: 1730501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames.
    Vergis JM; Cote CK; Bozue J; Alem F; Ventura CL; Welkos SL; O'Brien AD
    Clin Vaccine Immunol; 2013 Jan; 20(1):56-65. PubMed ID: 23114705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis.
    Ivins BE; Welkos SL
    Infect Immun; 1986 Nov; 54(2):537-42. PubMed ID: 3021632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis.
    Singh Y; Ivins BE; Leppla SH
    Infect Immun; 1998 Jul; 66(7):3447-8. PubMed ID: 9632621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
    Skoble J; Beaber JW; Gao Y; Lovchik JA; Sower LE; Liu W; Luckett W; Peterson JW; Calendar R; Portnoy DA; Lyons CR; Dubensky TW
    Infect Immun; 2009 Apr; 77(4):1649-63. PubMed ID: 19168734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain.
    Chitlaru T; Israeli M; Bar-Haim E; Elia U; Rotem S; Ehrlich S; Cohen O; Shafferman A
    Sci Rep; 2016 Jan; 6():18908. PubMed ID: 26732659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
    Little SF; Knudson GB
    Infect Immun; 1986 May; 52(2):509-12. PubMed ID: 3084385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization studies with attenuated strains of Bacillus anthracis.
    Ivins BE; Ezzell JW; Jemski J; Hedlund KW; Ristroph JD; Leppla SH
    Infect Immun; 1986 May; 52(2):454-8. PubMed ID: 3084383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.
    Cote CK; Kaatz L; Reinhardt J; Bozue J; Tobery SA; Bassett AD; Sanz P; Darnell SC; Alem F; O'Brien AD; Welkos SL
    J Med Microbiol; 2012 Oct; 61(Pt 10):1380-1392. PubMed ID: 22767539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.
    Iacono-Connors LC; Welkos SL; Ivins BE; Dalrymple JM
    Infect Immun; 1991 Jun; 59(6):1961-5. PubMed ID: 1903769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
    Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of the protective antigen of Bacillus anthracis on the formation of immunity under the action of live anthrax vaccines].
    Abalakin VA; Buravtseva NP; Cherkasskiĭ BL
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):72-5. PubMed ID: 2117320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines.
    Gat O; Inbar I; Aloni-Grinstein R; Zahavy E; Kronman C; Mendelson I; Cohen S; Velan B; Shafferman A
    Infect Immun; 2003 Feb; 71(2):801-13. PubMed ID: 12540560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs.
    Ivins BE; Fellows PF; Nelson GO
    Vaccine; 1994 Aug; 12(10):872-4. PubMed ID: 7975827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization.
    Kobiler D; Gozes Y; Rosenberg H; Marcus D; Reuveny S; Altboum Z
    Infect Immun; 2002 Feb; 70(2):544-60. PubMed ID: 11796581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.